CLINICAL_TRIALS
withdrawal
· 2016-04-01
Clinical Trial Update: The PALP™-COPD Trial (Low-Flow CO2-Removal (ECCO2-R) in Exacerbated COPD) [NA]
Summary
The PALP™-COPD trial evaluating low-flow CO2 removal (ECCO2-R) in exacerbated COPD has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Maquet Cardiopulmonary GmbH | Conditions: COPD, Chronic Obstructive Pulmonary Disease | NA | Status: WITHDRAWN